Description

2-Chloro-5,6,7,9,10,14B-Hexahydro-5-Methylisoquino[2,1-D][1,4]Benzodiazepine is a high-purity, complex heterocyclic compound of significant interest in advanced organic synthesis. This specialized chemical serves as a critical pharmacological intermediate and a versatile building block for research into novel therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the development of new chemical entities and active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel benzodiazepine analogs and other bioactive heterocyclic compounds for pharmacological screening.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Reference Standard: Serves as a high-purity analytical standard for quality control and method development in analytical laboratories.
• Academic & Institutional Research: Employed in universities and research institutes for studying complex organic reaction mechanisms and synthesizing novel molecular architectures.
• Fine Chemical Synthesis: Acts as a specialized building block for contract research organizations (CROs) and custom synthesis providers.

Basic Information

Product Name	2-Chloro-5,6,7,9,10,14B-Hexahydro-5-Methylisoquino[2,1-D][1,4]Benzodiazepine
CAS No.	17617-11-7
Molecular Formula	C₁₈H₁₉ClN₂
Molecular Weight	298.81 g/mol
Synonyms	5-Methyl-2-chloro-5,6,7,9,10,14b-hexahydroisoquino[2,1-d][1,4]benzodiazepine; 2-Chloro-5-methyl-5,6,7,9,10,14b-hexahydroisoquino[2,1-d][1,4]benzodiazepine; Isoquino[2,1-d][1,4]benzodiazepine, 2-chloro-5,6,7,9,10,14b-hexahydro-5-methyl-; 17617-11-7; 5-Methyl-2-chloro-5,6,7,9,10,14b-hexahydroisoquino[2,1-d]benzo[e][1,4]diazepine
EINECS	Contact for details

Quality Control

Our 2-Chloro-5,6,7,9,10,14B-Hexahydro-5-Methylisoquino[2,1-D][1,4]Benzodiazepine is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical characterization, including HPLC for purity and NMR/IR for structural confirmation, to ensure it meets the exacting standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided and available upon request to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.